Claim-specific evidence map
GHK-Cu Glutathione Histidine Clycine NADH
Cellular aging and longevity pathways
REVIEW IN PROGRESS
Current evidence
Evidence verification in progress
We are currently reviewing published research for this peptide and claim. An evidence level will appear after the sources and findings have completed editorial review.
- 1Laboratory
- 2Animal
- 3Early Human
- 4Controlled Human
- 5Established Use
No evidence level assigned — review in progress.
Level 3 is the first level that contains human evidence. Levels 1 and 2 are never human evidence.
Verified sources
0
Human studies
0
Preclinical studies
0
Last reviewed
Review in progress
Citation data is not currently present in the project for this claim. The citation system is ready for verified source import — no sample or placeholder studies are shown.
Evidence development timeline
Laboratory Research
Evidence review in progress. No verified citations have been published for this stage yet.
Animal Research
Evidence review in progress. No verified citations have been published for this stage yet.
Early Human Research
Evidence review in progress. No verified citations have been published for this stage yet.
Controlled Human Studies
Evidence review in progress. No verified citations have been published for this stage yet.
Regulatory Review or Established Clinical Use
Evidence review in progress. No verified citations have been published for this stage yet.
Related evidence maps
Educational information only. Not medical advice. No dosing, protocols, or purchasing guidance is provided. Evidence levels describe the research stage reached for the selected claim — not efficacy, safety, or suitability for any person.
Methodology and editorial review
- Evidence levels are assigned per claim, never to a peptide as a whole, using the five-level ladder (1 Laboratory, 2 Animal, 3 Early Human, 4 Controlled Human, 5 Regulatory Review or Established Clinical Use).
- Level 3 is the first level containing human evidence.
- Laboratory and animal findings are never described as proof of an effect in people.
- Blends never inherit or average the evidence levels of their components. Components are reviewed independently.
- Publication count is not treated as evidence quality, and popularity is never treated as evidence.
- Study titles, authors, journals, and links are published only after each source has been verified. Unreviewed claims stay visibly marked as unreviewed.
- Last review
- Not yet published
- Search cutoff date
- Published with the completed source library